-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ChapAte in Hemophilia A (Factor VIII Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ChapAte in Hemophilia A (Factor VIII Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ChapAte in Hemophilia A (Factor VIII Deficiency) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selectate in Hemophilia A (Factor VIII Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selectate in Hemophilia A (Factor VIII Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SelectAte in Hemophilia A (Factor VIII Deficiency) Drug Details:Antihemophilic factor...
-
Company Profile
Public Bank Berhad – Company Profile
Public Bank Berhad (PBB) is a provider of a range of commercial and consumer banking, investment banking, Islamic banking, trustee, stock-broking, and nominee services. It also sells and manages unit trust funds and life insurance products. Commercial banking products comprises lending, wealth management, transactional banking, treasury operations, and international banking solutions. Its consumer banking portfolio includes retail financing for passenger vehicles, residential properties, and personal needs, credit and debit cards, Shariah-compliant products and services, and deposits. PBB offers cash management,...
Add to Basket -
Company Profile
Deutsche Pfandbriefbank AG – Company Profile
Deutsche Pfandbriefbank AG (Pbb Group) is a provider of commercial real estate and public sector financing solutions and related services. The group’s portfolio of products comprises investment loans, development loans, cross-border portfolio financing, investment bridge finance facilities, acquisition/credit lines, derivatives, export finance, finance leasing, and public investment finance with a project property background. It offers financing solutions for office buildings, retail, residential and logistics properties, healthcare and nursing care properties, utilities and waste disposal, public housing and child-care and educational...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ChapAte
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ChapAte Drug Details Antihemophilic factor (ChapAte) is under development for the treatment of Hemophilia...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SelectAte
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SelectAte Drug Details Antihemophilic factor (SelectAte) is under development for the treatment of Haemophilia...